Biocon’s partner Mylan receives favourable ruling from US PTAB on Sanofi’s four device patents for… EP News Bureau Jun 1, 2020 Reportedly, the PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable.
